Security key
92764N102
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 139,483,767
- Total 13F value
- $1,248,624,974
- Share change
- +19,653,694
- Put/Call ratio
- 93%
- SEC-reported price per share
- $8.96
- Number of holders
- 250
- Value change
- +$201,072,475
- Number of buys
- 178
- Number of sells
- 70
- Shares outstanding
- 168,883,915
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
250
Top holders
10
VIR full security history
Ownership snapshot
Full 13F holder table
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of VIR - Vir Biotechnology, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 11%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
11%
ARCH Venture Fund IX, L.P.
8.5%
SB INVESTMENT ADVISERS (UK) LTD
6.5%
SVF Endurance (Cayman) Ltd
8.1%
ARCH Venture Management, LLC
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
11%
from 13D/G
|
$98,470,521
16,330,103 shares
|
— | 31 Dec 2025 |
| ARCH Venture Fund IX, L.P. |
13D/G
Robert Nelsen
|
8.5%
|
$101,645,627
13,534,704 shares
|
$0 | 27 Feb 2026 |
| SB INVESTMENT ADVISERS (UK) LTD |
13D/G
13F
SB Investment Advisers (UK) Limited · Company
|
6.5%
|
$118,567,847
10,948,093 shares
|
-$23,489,014 | 31 Mar 2026 |
| SVF Endurance (Cayman) Ltd |
3/4/5
10%+ Owner
|
8.1%
|
$82,134,660
13,728,924 shares
|
-$17,847,707 | 01 Dec 2025 |
| ARCH Venture Management, LLC |
13F
Company
|
7.6%
|
$77,887,478
12,916,663 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
7.4%
|
$75,670,133
12,548,944 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
250
Shares
139,483,767
Rows available
250
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
250
Q1 2026 holders
250
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|